Skip to content
healthcare.dev

Ixiaro

NDC 62195-051, Japanese Encephalitis Vaccine, Inactivated, Adsorbed, injection, suspension, from Vetter Pharma Fertigung GmbH & Co. KG.

Product NDC
62195-051
Status
Listed
Labeler
Vetter Pharma Fertigung GmbH & Co. KG
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125280
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62195-051 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)6 ug/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Inactivated Japanese Encephalitis Virus Vaccine [EPC]; Japanese Encephalitis Vaccines [CS]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
62195-051-0162195005101.5 mL in 1 SYRINGE (62195-051-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62195-051 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62195-051 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62195-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.